Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | serotonin transporter b | 0.0394 | 0.4407 | 0.4407 |
Echinococcus multilocularis | serotonin transporter | 0.0394 | 0.4407 | 0.4407 |
Toxoplasma gondii | hypothetical protein | 0.0067 | 0 | 0.5 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0067 | 0 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.081 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.081 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0394 | 0.4407 | 0.4407 |
Loa Loa (eye worm) | hypothetical protein | 0.0394 | 0.4407 | 0.4407 |
Plasmodium falciparum | transporter, putative | 0.0067 | 0 | 0.5 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0394 | 0.4407 | 1 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0067 | 0 | 0.5 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0394 | 0.4407 | 0.4407 |
Echinococcus granulosus | serotonin transporter | 0.0394 | 0.4407 | 0.4407 |
Plasmodium vivax | amine transporter, putative | 0.0067 | 0 | 0.5 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0394 | 0.4407 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.081 | 1 | 1 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0394 | 0.4407 | 0.4407 |
Chlamydia trachomatis | Ssodium-dependent amino acid transporter | 0.0067 | 0 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.081 | 1 | 1 |
Plasmodium falciparum | amino acid transporter, putative | 0.0067 | 0 | 0.5 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0394 | 0.4407 | 0.4407 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0394 | 0.4407 | 0.4407 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0067 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0067 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0067 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0394 | 0.4407 | 0.4407 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.081 | 1 | 1 |
Onchocerca volvulus | 0.0394 | 0.4407 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.224 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.119 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.